Consider BMD testing in the following individuals:

• Women age 65 and older and men age 70 and older, regardless of clinical risk factors
• Younger postmenopausal women, women in the menopausal transition, and men aged 50-69 with clinical risk factors for fracture
• Adults who have a fracture after age 50
• Adults with a condition (e.g., rheumatoid arthritis) or taking a medication (e.g., glucocorticoids in a daily dose ≥5-mg prednisone or equivalent for ≥3 months) associated with low bone mass or bone loss